Anesthetic Gel Recalled

An incorrect product formulation has prompted a recall of 190 syringes of LET gel topical anesthetic distributed by Right Value Drug Stores, which does business as Carie Boyd’s Prescription Shop. The December 13, 2023, US Food and Drug Administration (FDA) Enforcement Report included the recall but provided no further details about the formulation issues.

The recall affects LET gel (lidocaine 4%/epinephrine 0.18%/tetracaine 0.5%) 3-mL single-use syringes, in 10-syringe packs (NDC 73271-1003-1), from lot 092020237 (Exp. 3/18/24). The syringes were distributed by Carie Boyd Pharmaceuticals, Irving, Texas, throughout the US.

Right Value Drug Stores voluntarily initiated the recall on November 9, 2023. On December 6, 2023, the FDA designated the recall Class III, suggesting use of the recalled syringes is not likely to cause harm.

LET gel is a topical anesthetic used in medical settings to reduce pain during the suturing of wounds.